Stockholm - Delayed Quote SEK

Redsense Medical AB (REDS.ST)

5.84
+0.02
+(0.34%)
At close: May 9 at 1:52:21 PM GMT+2
Loading Chart for REDS.ST
  • Previous Close 5.82
  • Open 5.84
  • Bid 5.82 x --
  • Ask 6.50 x --
  • Day's Range 5.84 - 5.84
  • 52 Week Range 4.75 - 8.48
  • Volume 502
  • Avg. Volume 12,048
  • Market Cap (intraday) 96.038M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 292.00
  • EPS (TTM) 0.02
  • Earnings Date May 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe, Canada, and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an optic fiber and an absorbent sponge-like material. It also provides Redsense Clamp, an accessory to the alarm unit enabling automatic stop of the flow in the blood line in case of an incident, regardless of the type of dialysis machine. It serves the requirements of healthcare providers in the dialysis sector. Redsense Medical AB (publ) was founded in 2000 and is based in Halmstad, Sweden.

redsensemedical.com

5

Full Time Employees

December 31

Fiscal Year Ends

Recent News: REDS.ST

View More

Performance Overview: REDS.ST

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

REDS.ST
17.75%
OMX Stockholm 30 Index (^OMX)
1.38%

1-Year Return

REDS.ST
15.36%
OMX Stockholm 30 Index (^OMX)
5.41%

3-Year Return

REDS.ST
63.39%
OMX Stockholm 30 Index (^OMX)
27.89%

5-Year Return

REDS.ST
55.78%
OMX Stockholm 30 Index (^OMX)
56.66%

Compare To: REDS.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: REDS.ST

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    95.71M

  • Enterprise Value

    80.35M

  • Trailing P/E

    291.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.53

  • Price/Book (mrq)

    2.42

  • Enterprise Value/Revenue

    2.85

  • Enterprise Value/EBITDA

    180.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.19%

  • Return on Assets (ttm)

    0.38%

  • Return on Equity (ttm)

    1.09%

  • Revenue (ttm)

    28.77M

  • Net Income Avi to Common (ttm)

    342k

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.36M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3.18M

Research Analysis: REDS.ST

View More

Company Insights: REDS.ST

Research Reports: REDS.ST

View More

People Also Watch